TN SB0501

Expanding Medicaid To Provide Sickle Cell Treatment

Introduced Senate Raumesh Akbari (D)
Plain English Summary

This bill allows the governor of Tennessee to expand Medicaid eligibility specifically to provide treatment for individuals diagnosed with sickle cell disease. It aims to align with federal healthcare regulations and enables negotiations with federal agencies regarding the expansion terms.

At a Glance

TN SB0501 is a senate bill in the Tennessee 114th General Assembly, sponsored by Raumesh Akbari (D), currently “Introduced” since January 29, 2025.

We track 9,160 Tennessee bills this session, 237 of them sponsored by Raumesh Akbari.

Supporters Say

Supporters of the bill argue that expanding Medicaid for sickle cell treatment is a crucial step in improving health outcomes for those affected by this disease. They believe it demonstrates a commitment to providing necessary healthcare services to vulnerable populations and aligns with federal health initiatives.

Critics Say

Critics of the bill may contend that expanding Medicaid could lead to increased state spending and potential long-term financial burdens. They might also argue that the focus should be on broader healthcare reforms rather than targeted expansions that could set a precedent for further requests.

Conflict of Interest Analysis Personal Interests
2/10
Risk Level
Low
Policy Area
Health
Industry Overlap
0%
Personal Conflicts
0 found

The bill SB0501 aims to expand Medicaid eligibility specifically for the treatment of sickle cell disease, which falls under the health policy area. The sponsor, Raumesh Akbari, is an attorney and self-employed at Akbari Law, but there are no direct overlaps between her personal financial interests and the healthcare industry affected by this bill. While she is involved in public policy and has interests in various sectors, including beauty and cosmetology, these do not intersect with the Medicaid expansion for sickle cell treatment. Therefore, her personal financial interests do not present a conflict with the legislation's intent or potential impacts.

Sponsor's Personal Financial Interests

Unlike federal analysis based on campaign donations, state analysis examines legislators' personal financial interests — their jobs, businesses, and investments.

Type Description Industry Source
Occupation Attorney Lawyers/Law Firms AI-researched
Employer Self-employed at Akbari Law — TN Legislature bio
Board Member Board member of the National Black Caucus of State Legislators — AI-researched
Employer AKBARI CORPORATION — TN Ethics Commission
Employer DELIVER THE AMERICAN DREAM — TN Ethics Commission
Occupation Law, HAIR, COSMETOLOGY, BEAUTY, PUBLIC POLICY — TN Ethics Commission
Asset Leadership PAC: AKBARI PAC — TN Ethics Commission

Items marked "AI-researched" are generated from public sources but have not been independently verified. Verified data is sourced from official legislature websites and disclosure filings.

TheBillRoom is free and independent. No ads, no subscriptions, no political funding. If this analysis was useful, reader support keeps it running.
Support Us

About This Analysis

This summary was generated using AI from the bill's official text and metadata. Data sourced from LegiScan and the Tennessee General Assembly. Conflict analysis examines the sponsor's personal financial interests for potential overlaps with the bill's subject matter.

Frequently Asked Questions
What does TN SB0501 do?

This bill allows the governor of Tennessee to expand Medicaid eligibility specifically to provide treatment for individuals diagnosed with sickle cell disease. It aims to align with federal healthcare regulations and enables negotiations with federal agencies regarding the expansion terms.

What is the status of TN SB0501?

TN SB0501 is currently “Introduced” in the Tennessee legislature.

Who sponsored TN SB0501?

Raumesh Akbari (D) sponsored TN SB0501.